Values of SARS-CoV-2 anti-spike, neutralizing antibodies and IFN-γ producing T cells at days 21 and 42 after the first dose of Pfizer-BioNTech COVID-19 vaccine. This evidence concerns the gene CHMP5 and COVID-19.